Changes in Self-Reported Dentine Hypersensitivity Experience following SnF 2 Toothpaste Use

OBJECTIVES: To evaluate the changes in oral health-related quality of life (OHrQoL) and self-perceived dentine hypersensitivity (DH) outcomes following the use of a marketed anhydrous 0.454% stannous fluoride toothpaste in individuals with self-reported DH in a real-world setting. METHODS: Healthy adults, aged 18 to 65 y with self-reported DH, provided informed consent and were recruited via digital platforms into this decentralized, prospective, open-label real-world study (536 enrolled, 498 reported using product, 460 completed). Participants used Sensodyne Repair & Protect toothpaste (USA; 1,100 ppm F as stannous fluoride, in marketed packaging) and were instructed to follow the on-pack brushing directions within their normal oral hygiene routine. All participant-reported assessments were completed remotely using an online app. Participants completed a validated DH Experience Questionnaire (DHEQ-48) every 4 wk for 24 wk to capture patient-reported OHrQoL and DH experiences. They also self-reported DH-related pain using a Numeric Pain Rating Scale (NPRS) and rated treatment satisfaction at study completion. No in-clinic visits occurred in this fully decentralized study. RESULTS: < 0.0001). This demonstrated progressive improvement in OHrQoL over the 24-wk study: improvements were consistently observed across all 5 domains. Participants also recorded that their DH was progressively and significantly less intense, less bothersome, and more tolerable as the study progressed. NPRS evaluation paralleled the DHEQ results, showing reduced perception of DH pain: baseline = 5.7 (0.10), week 4 = 4.1 (0.10), and week 24 = 2.5 (0.11) (maximum = 10). Participants reported being highly satisfied with the product, with 66.2% ranking it at least 8/10. CONCLUSIONS: This study showed that the long-term use of a marketed anhydrous 0.454% stannous fluoride toothpaste was associated with meaningful improvements in patient-reported OHrQoL and reductions in perceived DH pain among self-reported DH sufferers in a real-world setting.Knowledge Transfer Statement:In a real-world setting, participants reported meaningful improvements in oral health-related quality of life and reduced perceived dentine hypersensitivity pain while using a marketed, open-label anhydrous stannous fluoride toothpaste over 6 mo.

Authors

Institutions

Publication Details

Journal
JDR Clinical & Translational Research
Published
2026-11-20
DOI
https://doi.org/10.1177/23800844261500066
Primary Topic
Dental Erosion and Treatment
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Changes in Self-Reported Dentine Hypersensitivity Experience following SnF 2 Toothpaste Use

Jonathan E. Creeth, P. Gomez Pereira, G. Smith, B. Wilson et al.
JDR Clinical & Translational Research
Dental Erosion and Treatment
article

Changes in Self-Reported Dentine Hypersensitivity Experience following SnF 2 Toothpaste Use

Jonathan E. Creeth, P. Gomez Pereira, G. Smith, B. Wilson, J. Qiu
article en

Abstract

OBJECTIVES: To evaluate the changes in oral health-related quality of life (OHrQoL) and self-perceived dentine hypersensitivity (DH) outcomes following the use of a marketed anhydrous 0.454% stannous fluoride toothpaste in individuals with self-reported DH in a real-world setting. METHODS: Healthy adults, aged 18 to 65 y with self-reported DH, provided informed consent and were recruited via digital platforms into this decentralized, prospective, open-label real-world study (536 enrolled, 498 reported using product, 460 completed). Participants used Sensodyne Repair & Protect toothpaste (USA; 1,100 ppm F as stannous fluoride, in marketed packaging) and were instructed to follow the on-pack brushing directions within their normal oral hygiene routine. All participant-reported assessments were completed remotely using an online app. Participants completed a validated DH Experience Questionnaire (DHEQ-48) every 4 wk for 24 wk to capture patient-reported OHrQoL and DH experiences. They also self-reported DH-related pain using a Numeric Pain Rating Scale (NPRS) and rated treatment satisfaction at study completion. No in-clinic visits occurred in this fully decentralized study. RESULTS: < 0.0001). This demonstrated progressive improvement in OHrQoL over the 24-wk study: improvements were consistently observed across all 5 domains. Participants also recorded that their DH was progressively and significantly less intense, less bothersome, and more tolerable as the study progressed. NPRS evaluation paralleled the DHEQ results, showing reduced perception of DH pain: baseline = 5.7 (0.10), week 4 = 4.1 (0.10), and week 24 = 2.5 (0.11) (maximum = 10). Participants reported being highly satisfied with the product, with 66.2% ranking it at least 8/10. CONCLUSIONS: This study showed that the long-term use of a marketed anhydrous 0.454% stannous fluoride toothpaste was associated with meaningful improvements in patient-reported OHrQoL and reductions in perceived DH pain among self-reported DH sufferers in a real-world setting.Knowledge Transfer Statement:In a real-world setting, participants reported meaningful improvements in oral health-related quality of life and reduced perceived dentine hypersensitivity pain while using a marketed, open-label anhydrous stannous fluoride toothpaste over 6 mo.

JDR Clinical & Translational Research
Hal Technology (United States) (US), Haleon (United Kingdom) (GB)
Dental Erosion and Treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon